68 related articles for article (PubMed ID: 9333292)
1. [Receptor mediated gene transfer in squamous epithelial carcinoma of the head-neck area].
Wollenberg B; Schmidt W; Schmitt B; Lang S; Zeidler R
Laryngorhinootologie; 1997 Jul; 76(7):411-4. PubMed ID: 9333292
[TBL] [Abstract][Full Text] [Related]
2. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
Li D; Duan L; Freimuth P; O'Malley BW
Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of transfection rates on head and neck squamous cell cancer by a novel adenovirus: an in vivo and in vitro study.
Lalonde ES; Beyer G; Friedlander PL; Kolls JK
Head Neck; 2002 Dec; 24(12):1038-46. PubMed ID: 12454941
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.
Liu TJ; el-Naggar AK; McDonnell TJ; Steck KD; Wang M; Taylor DL; Clayman GL
Cancer Res; 1995 Jul; 55(14):3117-22. PubMed ID: 7606733
[TBL] [Abstract][Full Text] [Related]
5. [Somatic gene therapy in squamous epithelial carcinomas of the head-neck area].
Wollenberg B; Naujoks K; Kastenbauer E
Laryngorhinootologie; 1996 Jun; 75(6):356-62. PubMed ID: 8766383
[TBL] [Abstract][Full Text] [Related]
6. Cationic liposome-enhanced adenoviral gene transfer in a murine head and neck cancer model.
Sung MW; Lee SG; Yoon SJ; Lee HJ; Heo DS; Kim KH; Koh TY; Choi SH; Park SW; Koo JW; Kwon TY
Anticancer Res; 2000; 20(3A):1653-6. PubMed ID: 10928086
[TBL] [Abstract][Full Text] [Related]
7. Novel adenoviral gene delivery system targeted against head and neck cancer.
Li D; Guang W; Abuzeid WM; Roy S; Gao GP; Sauk JJ; O'Malley BW
Laryngoscope; 2008 Apr; 118(4):650-8. PubMed ID: 18176343
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model.
Eicher SA; Clayman GL; Liu TJ; Shillitoe EJ; Storthz KA; Roth JA; Lotan R
Clin Cancer Res; 1996 Oct; 2(10):1659-64. PubMed ID: 9816113
[TBL] [Abstract][Full Text] [Related]
9. Head and neck cancer cells are efficiently infected by Ad5/35 hybrid virus.
Suominen E; Toivonen R; Grenman R; Savontaus M
J Gene Med; 2006 Oct; 8(10):1223-31. PubMed ID: 16941521
[TBL] [Abstract][Full Text] [Related]
10. A replication-selective adenoviral vector for head and neck cancers.
Tanaka H; Shirakawa T; Zhang Z; Hamada K; Gotoh A; Nibu K
Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):630-4. PubMed ID: 16027288
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model.
O'Malley BW; Chen SH; Schwartz MR; Woo SL
Cancer Res; 1995 Mar; 55(5):1080-5. PubMed ID: 7866992
[TBL] [Abstract][Full Text] [Related]
12. Sustained gene transfer and enhanced cell death following glucosylated-PEI-mediated p53 gene transfer with photochemical internalisation in p53-mutated head and neck carcinoma cells.
Ndoye A; Bouali S; Dolivet G; Leroux A; Erbacher P; Behr JP; Berg K; Guillemin F; Merlin JL
Int J Oncol; 2004 Dec; 25(6):1575-81. PubMed ID: 15547693
[TBL] [Abstract][Full Text] [Related]
13. Recombinant adenovirus-mediated gene transfer to genitourinary epithelium in vitro and in vivo.
Bass C; Cabrera G; Elgavish A; Robert B; Siegal GP; Anderson SC; Maneval DC; Curiel DT
Cancer Gene Ther; 1995 Jun; 2(2):97-104. PubMed ID: 7621262
[TBL] [Abstract][Full Text] [Related]
14. Development of transferrin-polycation/DNA based vectors for gene delivery to melanoma cells.
Wightman L; Patzelt E; Wagner E; Kircheis R
J Drug Target; 1999 Dec; 7(4):293-303. PubMed ID: 10682908
[TBL] [Abstract][Full Text] [Related]
15. All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma.
Nakashima T; Sun SY; Lotan R; Fujiwara T; Yasumatsu R; Komiyama S; Clayman GL
Laryngoscope; 2001 Aug; 111(8):1459-64. PubMed ID: 11568584
[TBL] [Abstract][Full Text] [Related]
16. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma.
Nakashima T; Yasumatsu R; Kuratomi Y; Masuda M; Kuwano T; Toh S; Umezaki T; Cataltepe S; Silverman GA; Komune S
Head Neck; 2006 Jan; 28(1):24-30. PubMed ID: 16155915
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of Cisplatin sensitivity in squamous cell carcinoma of the head and neck transfected with a survivin antisense gene.
Kojima H; Iida M; Yaguchi Y; Suzuki R; Hayashi N; Moriyama H; Manome Y
Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):682-5. PubMed ID: 16785416
[TBL] [Abstract][Full Text] [Related]
18. Alloantigen gene therapy for head and neck cancer: evaluation of animal models.
Gleich LL; Li YQ; Li S; Gluckman JL; Stambrook PJ
Head Neck; 2003 Apr; 25(4):274-9. PubMed ID: 12658731
[TBL] [Abstract][Full Text] [Related]
19. FasL gene therapy: a new therapeutic modality for head and neck cancer.
ElOjeimy S; McKillop JC; El-Zawahry AM; Holman DH; Liu X; Schwartz DA; Day TA; Dong JY; Norris JS
Cancer Gene Ther; 2006 Aug; 13(8):739-45. PubMed ID: 16543918
[TBL] [Abstract][Full Text] [Related]
20. E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines.
Zhang SY; Liu SC; Johnson DG; Klein-Szanto AJ
Cancer Res; 2000 Nov; 60(21):5972-6. PubMed ID: 11085515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
